Patents by Inventor Dirk Heinz

Dirk Heinz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5180667
    Abstract: DNA encoding novel eglin mutants that differ from the natural eglins B and C by the replacement of amino acids in the region of the active center (amino acid 45) by other amino acids are provided. The mutants, which are produced by recombinant genetic engineering, have valuable pharmacological properties.
    Type: Grant
    Filed: October 11, 1991
    Date of Patent: January 19, 1993
    Assignees: Ciba-Geigy Corporation, UCP Gen-Pharma, AG
    Inventors: Markus G. Grutter, Dirk Heinz, Manfred Liersch
  • Patent number: 5079229
    Abstract: Novel elgin mutants that differ from the natural eglins B and C by the replacement of one, two or three amino acids in the region of the active center (amino acids 45 and 46, Leu-Asp) by other amino acids are provided. The mutants, which can be produced by recombinant genetic engineering, have valuable pharmacological properties.
    Type: Grant
    Filed: March 7, 1989
    Date of Patent: January 7, 1992
    Assignee: Ciba-Geigy Corporation
    Inventors: Markus G. Grutter, Dirk Heinz, Manfred Liersch